Clinical significance of a NAD(P)H: Quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C

Ronald A. Fleming, Jeffrey Drees, Brian W. Loggie, Gregory B. Russell, Kim R. Geisinger, Reba T. Morris, Debbie Sachs, Richard P. McQuellon

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint Dive into the research topics of 'Clinical significance of a NAD(P)H: Quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C'. Together they form a unique fingerprint.

Medicine & Life Sciences